info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Mini ReviewOpen Access

Cardiovascular Disease Prevention: New Nutrigenetics Tests

Volume 5 - Issue 4

AV Nagay*, GA Khamidullaeva and RD Kurbanov

  • Author Information Open or Close
    • Department of Arterial Hypertension and Molecular Genetics Research, Republican Specialized Scientific-practical Medical Center of Cardiology, Tashkent, Uzbekistan

    *Corresponding author: Aleksandr Nagay, Department of Arterial Hypertension and Molecular Genetics Research, Republican Specialized Scientificpractical Medical Center of Cardiology 4, Osiyo Str Mirzo-Ulugbek 100052, Tashkent Uzbekistan

Received: June 11, 2018;   Published: June 15, 2018

DOI: 10.26717/BJSTR.2018.05.001234

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Nutrigenetics testing undoubtedly is an important part in clinical practice. Each patient has a combination of the genes bound to cardiovascular illnesses. We represent step-by-step the projection of Nutrigenetics tests for cardiologists. We represent the multiplex DNA system with technology of the effective analysis of genes. The technology of the effective genes analysis is the combined method of the sequential analysis, ROC-curve and relative risk of RR (Altman’s theorem) with use of basic mathematical algorithms (Bayes’ theorem) in diagnostics of in vitro. For the first time we applied this technology for identification of genes mutations which enlarge a susceptibility to rising of weight, and also sensitivities to some ions. Thus, using DNA identification, the developed algorithm can recommend an individual diet.

Keywords: Hypertensive Patient; Residual Risk; Prognostic Model; Nutrigenetics Panel; Nutrigenetics Tests

Introduction| Genotypes| Nutrigenetics Panel/ Prognostic Model| Integration into Working Processes| References|